Literature DB >> 23603385

How to measure hazards/risks following exposures to nanoscale or pigment-grade titanium dioxide particles.

David B Warheit1.   

Abstract

Due to its multifunctional applications, titanium dioxide particles have widespread use in commerce. The particle-types function as sources of pigment color, in food products, anti-bacterial components, ultraviolet radiation scavengers, catalysts, as well as in cosmetics. Because of its inherent properties in a diverse number of products, exposures may occur via any of the major point-of-entry routes, i.e., inhalation, oral or dermal. Although the majority of TiO2 applications are known to exist in the pigment-grade form, nanoscale forms of TiO2 are also common components in several products. This brief review is designed to identify relevant toxicology and risk-related issues which inform health effects assessments on the various forms of titanium dioxide particles. While there has been an abundance of hazard data generated on titanium dioxide particulates, many of the published reports have limited informational value for assessing health effects due, in large part, to shortcomings in experimental design issues, such as: (1) inadequate material characterization of test samples; (2) questionable relevance of experimental systems employed to simulate human exposures; (3) applications of generally high doses, exclusive focus on acute toxicity endpoints, and a lack of reference benchmark control materials, to afford interpretation of measured results; and/or (4) failure to recognize fundamental differences between hazard and risk concepts. Accordingly, a number of important toxicology issues are identified and integrated herein to provide a more comprehensive assessment of the health risks of different forms of pigment-grade and nanoscale titanium dioxide particles. It is important to note that particle-types of different TiO2 compositions may have variable toxicity potencies, depending upon crystal structure, particle size, particle surface characteristics and surface coatings. In order to develop a more robust health risk evaluation of TiO2 particle exposures, this review focuses on the following issues: (1) Introduction to TiO2 particle chemistry/functionality and importance of robust material characterization of test samples; (2) Implementation of meaningful hazard studies for gauging EHS safety issues – pulmonary bioassay data and development of the Nano Risk Framework for developmental nano TiO2 compounds; (3) Epidemiological study findings on titanium dioxide workers – the most heavily-exposed populations; (4) Methodologies for setting occupational exposure limits including benchmarking or bridging comparisons; and (5) The importance of particle overload data in the lungs of rats as it relates to gauging the relevance of health effects for humans. A comprehensive evaluation of the existing animal and human health data is a necessary prerequisite for facilitating accurate assessments of human health risks to TiO2 exposures.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23603385     DOI: 10.1016/j.toxlet.2013.04.002

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  11 in total

Review 1.  Titanium Dioxide: Structure, Impact, and Toxicity.

Authors:  Anca Diana Racovita
Journal:  Int J Environ Res Public Health       Date:  2022-05-06       Impact factor: 4.614

Review 2.  Applied Nanotoxicology.

Authors:  David W Hobson; Stephen M Roberts; Anna A Shvedova; David B Warheit; Georgia K Hinkley; Robin C Guy
Journal:  Int J Toxicol       Date:  2016 Jan-Feb       Impact factor: 2.032

3.  Antibacterial performance of nanocrystallined titania confined in mesoporous silica nanotubes.

Authors:  Krzysztof Cendrowski; Magdalena Peruzynska; Agata Markowska-Szczupak; Xuecheng Chen; Anna Wajda; Joanna Lapczuk; Mateusz Kurzawski; Ryszard J Kalenczuk; Marek Drozdzik; Ewa Mijowska
Journal:  Biomed Microdevices       Date:  2014-06       Impact factor: 2.838

4.  A comparison of conventional methods for the quantification of bacterial cells after exposure to metal oxide nanoparticles.

Authors:  Hongmiao Pan; Yongbin Zhang; Gui-Xin He; Namrata Katagori; Huizhong Chen
Journal:  BMC Microbiol       Date:  2014-08-21       Impact factor: 3.605

5.  Pulmonary responses in rat lungs after intratracheal instillation of 4 crystal forms of titanium dioxide nanoparticles.

Authors:  Takami Okada; Akira Ogami; Byeong Woo Lee; Chikara Kadoya; Takako Oyabu; Toshihiko Myojo
Journal:  J Occup Health       Date:  2016-09-30       Impact factor: 2.708

6.  Environmental disinfection with photocatalyst as an adjunctive measure to control transmission of methicillin-resistant Staphylococcus aureus: a prospective cohort study in a high-incidence setting.

Authors:  Min Hyung Kim; Seong Gyu Lee; Ki Sook Kim; Yoon Ji Heo; Ji Eun Oh; Su Jin Jeong
Journal:  BMC Infect Dis       Date:  2018-12-03       Impact factor: 3.090

7.  Pulmonary dust foci as rat pneumoconiosis lesion induced by titanium dioxide nanoparticles in 13-week inhalation study.

Authors:  Yuko Goto; Tomoki Takeda; Shotaro Yamano; Shigeyuki Hirai; Yusuke Furukawa; Yoshinori Kikuchi; Tatsuya Kasai; Kyohei Misumi; Masaaki Suzuki; Kenji Takanobu; Hideki Senoh; Misae Saito; Hitomi Kondo; Yumi Umeda
Journal:  Part Fibre Toxicol       Date:  2022-09-14       Impact factor: 9.112

Review 8.  Usefulness of Intratracheal Instillation Studies for Estimating Nanoparticle-Induced Pulmonary Toxicity.

Authors:  Yasuo Morimoto; Hiroto Izumi; Yukiko Yoshiura; Kei Fujishima; Kazuhiro Yatera; Kazuhiro Yamamoto
Journal:  Int J Mol Sci       Date:  2016-01-27       Impact factor: 5.923

Review 9.  Hazard and risk assessment strategies for nanoparticle exposures: how far have we come in the past 10 years?

Authors:  David B Warheit
Journal:  F1000Res       Date:  2018-03-26

10.  Synthesis and investigations on tellurium myconanoparticles.

Authors:  Mostafa M Abo Elsoud; Ola E A Al-Hagar; Eman S Abdelkhalek; N M Sidkey
Journal:  Biotechnol Rep (Amst)       Date:  2018-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.